Plasma antithrombin activity as a diagnostic and prognostic indicator in dogs: A retrospective study of 149 dogs

Journal of Veterinary Internal Medicine

Volumn 24, Issue 3, 2010, Pages 587-596

  Kuzi, S ^a   Segev, G ^a   Haruvi, E ^a   Aroch, I ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Canine; Hypercoagulability; Outcome; Prognosis; Thrombosis

Indexed keywords

ANTITHROMBIN;

ANIMAL; ARTICLE; BLOOD; DOG; DOG DISEASE; FEMALE; GENETIC SCREENING; MALE; METABOLISM; RETROSPECTIVE STUDY;

ANIMALS; ANTITHROMBINS; DOG DISEASES; DOGS; FEMALE; GENETIC TESTING; MALE; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 77954358991     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0497.x     Document Type: Article

References (45)

1. Green RA. Pathophysiology of antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988, 18:95-104.
2. Welles EG. Antithrombotic and fibrinolytic factors. A review. Vet Clin North Am Small Anim Pract 1996, 26:1111-1127.
3. Bateman SW, Mathews KA, Abrams-Ogg AC. Evaluation of point-of-care tests for diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J Am Vet Med Assoc 1999, 215:805-810.
4. van der Merwe L, Reyers F. The effect of hemolysis on plasma antithrombin activity as determined by a chromogenic method. Vet Clin Pathol 2007, 36:55-59.
5. Feldman BF, Kirby R, Caldin M. Recognition and treatment of disseminated intravascular coagulation. Kirk's Current Veterinary Therapy XIII 2000, 190-194. Bonagura JD,. ed, London, Saunders
6. Green RA. Clinical implications of antithrombin III deficiency in animal diseases. Comp Cont Educ Pract Vet 1984, 6:537-545.
7. Blauhut B, Kramar H, Vinazzer H. Substitution of antithrombin III in shock and DIC: A randomized study. Thromb Res 1985, 39:81-89.
8. McGann MA, Triplett DA. Interpretation of antithrombin III activity. Lab Med 1982, 13:742-749.
9. Owings JT, Bagley M, Gosselin R. Effect of critical injury on plasma antithrombin activity: Low antithrombin levels are associated with thromboembolic complications. J Trauma 1996, 41:396-405.
10. Taylor FB, Emerson TE, Jordan R. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 1988, 26:227-235.
11. Dereszynski DM, Center SA, Randolph JF. Clinical and clinicopathologic features of dogs that consumed foodborne hepatotoxic aflatoxins: 72 cases (2005-2006). J Am Vet Med Assoc 2008, 232:1329-1337.
12. Mischke R, Pohle D, Schoon HA. Alterations of hemostasis in liver cirrhosis of the dog. Dtsch Tierarztl Wochenschr 1998, 105:43-47.
13. Toulza O, Center SA, Brooks MB. Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. J Am Vet Med Assoc 2006, 229:1761-1771.
14. de Laforcade AM, Freeman LM, Shaw SP. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003, 17:674-679.
15. de Laforcade AM, Rozanski EA, Freeman LM. Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med 2008, 22:26-30.
16. Bateman SW, Mathews KA, Abrams-Ogg AC. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J Am Vet Med Assoc 1999, 215:798-804.
17. Wiinberg B, Jensen AL, Johansson PI. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008, 22:357-365.
18. Abdullah R. Hemostatic abnormalities in nephrotic syndrome. Vet Clin North Am Small Anim Pract 1988, 18:105-113.
19. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: A review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996, 32:313-322.
20. Green RA. Posterior aortic thrombosis secondary to glomerulonephritis and acquired antithrombin III deficiency. Vet Clin North Am Small Anim Pract 1988, 18:263-264.
21. Mischke R. Changes in hemostasis in dogs with chronic renal insufficiency. Berl Munch Tierarztl Wochenschr 1997, 110:445-450.
22. Ritt MG, Rogers KS, Thomas JS. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog. J Am Anim Hosp Assoc 1997, 33:385-391.
23. Tarnow I, Falk T, Tidholm A. Hemostatic biomarkers in dogs with chronic congestive heart failure. J Vet Intern Med 2007, 21:451-457.
24. Mischke R. Acute haemostatic changes in accidentally traumatised dogs. Vet J 2005, 169:60-64.
25. Maruyama H, Watari T, Miura T. Plasma thrombin-antithrombin complex concentrations in dogs with malignant tumours. Vet Rec 2005, 156:839-840.
26. Mischke R, Freund M, Leinemann-Fink T. Changes in hemostasis of dogs with acute lymphoblastic leukemia. Berl Munch Tierarztl Wochenschr 1998, 111:53-59.
27. Stockhaus C, Kohn B, Rudolph R. Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract 1999, 40:326-331.
28. Mischke R. Hemostatic disorders as a complication of autoimmune hemolytic anemia in dogs. Dtsch Tierarztl Wochenschr 1998, 105:13-16.
29. Scott-Moncrieff JC, Treadwell NG, McCullough SM. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001, 37:220-227.
30. Lara-Garcia A, Couto CG, Iazbik MC. Postoperative bleeding in retired racing greyhounds. J Vet Intern Med 2008, 22:525-533.
31. Millis DL, Hauptman JG, Richter M. Preoperative and postoperative hemostatic profiles of dogs undergoing ovariohysterectomy. Cornell Vet 1992, 82:465-470.
32. Mammen EF. Clinical relevance of antithrombin deficiencies. Semin Hematol 1995, 32:2-6. discussion 7
33. Clare AC, Kraje BJ. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 1998, 212:539-543.
34. Yamashita K, Fujinaga T, Miyamoto T. Canine acute phase response: Relationship between serum cytokine activity and acute phase protein in dogs. J Vet Med Sci 1994, 56:487-492.
35. Tanaka H, Kobayashi N, Maekawa T. Studies on production of antithrombin III with special reference to endotoxin-induced DIC in dogs. Thromb Haemost 1986, 56:137-143.
36. Thompson MF, Scott-Moncrieff JC, Brooks MB. Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2004, 40:446-454.
37. Hess RS, Saunders HM, Van Winkle TJ. Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986-1995). J Am Vet Med Assoc 1998, 213:665-670.
38. Izquierdo R, Sandberg L, Nora MO. Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitis. J Surg Res 1984, 36:606-613.
39. Williams DA, Steiner JM. Canine exocrine pancreatic disease. Textbook of Veterinary Internal Medicine 2005, 1482-1489. Ettinger SJ, Feldman EC. eds, 6th ed, St Louis, MO, Elsevier Saunders
40. Nobar SM, Guy-Crotte O, Rabaud M. Inhibition of human pancreatic proteinases by human plasma α2-antiplasmin and antithrombin. Biol Chem 2004, 385:423-427.
41. Torry RJ, Labarrere CA, Nelson D. Localization and characterization of antithrombin in human kidneys. J Histochem Cytochem 1999, 47:313-322.
42. Kimmel SE, Waddell LS, Michel KE. Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire Terriers: Five cases (1992-1998). J Am Vet Med Assoc 2000, 217:703-706.
43. Kull PA, Hess RS, Craig LE. Clinical, clinicopathologic, radiographic, and ultrasonographic characteristics of intestinal lymphangiectasia in dogs: 17 cases (1996-1998). J Am Vet Med Assoc 2001, 219:197-202.
44. Littman MP, Dambach DM, Vaden SL. Familial protein-losing enteropathy and protein-losing nephropathy in soft coated Wheaten Terriers: 222 cases (1983-1997). J Vet Intern Med 2000, 14:68-80.
45. Willard MD, Helman G, Fradkin JM. Intestinal crypt lesions associated with protein-losing enteropathy in the dog. J Vet Intern Med 2000, 14:298-307.